Class Action Lawsuit Against Elanco Animal Health Incorporated (ELAN): The complaint alleges that the company minimized potential safety risks associated with Zenrelia, an oral Janus kinase inhibitor, ...

A review discussing the therapeutic potentials of NK cell biology has been published in the journal Frontiers of Medicine.

From tumor necrosis factor alpha (TNF-α), to IL-17 inhibitors, and then to IL-23 inhibitors, biologics have brought new light to the treatment of psoriasis again. In recent years, the exploration of ...

In a significant development, the pharmaceutical major Dr Reddys Laboratories has got the go-ahead from the Subject Expert ...

NEW YORK, NY / ACCESSWIRE / November 28, 2024 / If you suffered a loss on your Elanco Animal Health Incorporated (NYSE:ELAN) investment and want ...

Innovent Biologics, Inc. ('Innovent') (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and ...

Discover which therapies are expected to grab the PD/L-1 Market Share @ PD/L-1 Treatment Market Size ...

NEW YORK, NY / ACCESSWIRE / November 27, 2024 / If you suffered a loss on your Elanco Animal Health Incorporated (NYSE:ELAN) investment and want ...

The Biden administration on Tuesday proposed expanding drug coverage under Medicare and Medicaid to include anti-obesity ...

STC-15, an investigational RNA methyltransferase inhibitor, has shown promising clinical activity and an encouraging safety ...

Tiragolumab missed the chance to prove a survival benefit in SKYSCRAPER-01 adding to previous trial failures for the ...